Assignee
INTERVET INC
US·202 granted patents·149 pending applications·349 citations·filing 1980–2025
Top patents by PatentIndex Score
351 records- 0195US10106607B2Caninized antibodiesINTERVET INC·Filed 2014·Granted Oct 23, 2018·22 cites·14 claims
- 0294US9532978B2Topical localized isoxazoline formulationINTERVET INC·Filed 2015·Granted Jan 3, 2017·13 cites·10 claims
- 0393US11285101B2Soft chewable pharmaceutical productsINTERVET INC·Filed 2019·Granted Mar 29, 2022·6 cites·26 claims
- 0493US10751403B2Vaccine for protection against Streptococcus suisINTERVET INC·Filed 2019·Granted Aug 25, 2020·6 cites·13 claims
- 0592US9944704B2Antibodies against canine PD-1INTERVET INC·Filed 2014·Granted Apr 17, 2018·8 cites·5 claims
- 0691US12128032B2Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultryINTERVET INC·Filed 2022·Granted Oct 29, 2024·1 cites·5 claims
- 0791US11680097B2Antibodies against canine PD-1INTERVET INC·Filed 2020·Granted Jun 20, 2023·2 cites·10 claims
- 0891US11229698B2Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigensINTERVET INC·Filed 2018·Granted Jan 25, 2022·5 cites·20 claims
- 0989US11167021B2Vaccine for protection against Streptococcus suisINTERVET INC·Filed 2018·Granted Nov 9, 2021·3 cites·6 claims
- 1089US11103569B2Vaccine for protection against Streptococcus suisINTERVET INC·Filed 2018·Granted Aug 31, 2021·3 cites·5 claims
- 1189US10863727B2Method for automatic sea lice monitoring in salmon aquacultureINTERVET INC·Filed 2016·Granted Dec 15, 2020·12 cites·18 claims
- 1289US10653675B2Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultryINTERVET INC·Filed 2019·Granted May 19, 2020·4 cites·25 claims
- 1389US10023636B2Caninized murine antibodies to human PD-1INTERVET INC·Filed 2014·Granted Jul 17, 2018·5 cites·4 claims
- 1489US8044102B2Compositions and method for treating infection in cattle and swineINTERVET INC·Filed 2005·Granted Oct 25, 2011·16 cites·1 claims
- 1588US11337917B2Soft chewable pharmaceutical productsINTERVET INC·Filed 2017·Granted May 24, 2022·4 cites·19 claims
- 1688US11248047B2Caninized antibodiesINTERVET INC·Filed 2018·Granted Feb 15, 2022·2 cites·16 claims
- 1788US11229699B2Feline calicivirus vaccineINTERVET INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 1888US10864195B2Topical localized isoxazoline formulationINTERVET INC·Filed 2017·Granted Dec 15, 2020·3 cites·15 claims
- 1988US9314519B2Liquid stable virus vaccinesINTERVET INC·Filed 2013·Granted Apr 19, 2016·7 cites·21 claims
- 2087US12383610B2Vaccine for protection against Streptococcus suis serotype 9, sequence type 16INTERVET INC·Filed 2021·Granted Aug 12, 2025·1 cites·14 claims
- 2187US11311616B2Feline leukemia virus vaccineINTERVET INC·Filed 2018·Granted Apr 26, 2022·2 cites·20 claims
- 2287US10973759B2Manufacturing of semi-plastic pharmaceutical dosage unitsINTERVET INC·Filed 2019·Granted Apr 13, 2021·3 cites·13 claims
- 2387US10927172B2Caninized murine antibodies to human PD-1INTERVET INC·Filed 2018·Granted Feb 23, 2021·2 cites·10 claims
- 2487US10711061B2Antibodies against canine PD-1INTERVET INC·Filed 2018·Granted Jul 14, 2020·2 cites·17 claims
- 2587US9599607B2Potency test for vaccine formulationsINTERVET INC·Filed 2014·Granted Mar 21, 2017·5 cites·29 claims
- 2686US11883530B2Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animalsINTERVET INC·Filed 2021·Granted Jan 30, 2024·1 cites·12 claims
- 2786US11167027B2Multivalent feline vaccineINTERVET INC·Filed 2018·Granted Nov 9, 2021·2 cites·20 claims
- 2886US11034650B2Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infectionINTERVET INC·Filed 2017·Granted Jun 15, 2021·2 cites·4 claims
- 2986US7732187B2Recombinant attenuated clostridium organisms and vaccineINTERVET INC·Filed 2007·Granted Jun 8, 2010·9 cites·29 claims
- 3086US7713950B2Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereofINTERVET INC·Filed 2008·Granted May 11, 2010·8 cites·4 claims
- 3186US2023320981A1Solid oral pharmaceutical compositions for isoxazoline compoundsINTERVET INC·Filed 2023·Application pending·0 cites
- 3285US11447561B2PD-L1 antibodies binding canine PD-L1INTERVET INC·Filed 2019·Granted Sep 20, 2022·2 cites·12 claims
- 3385US11406617B2Compounds for the treatment of bovine or swine respiratory diseaseINTERVET INC·Filed 2017·Granted Aug 9, 2022·2 cites·2 claims
- 3485US8932604B2Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigensINTERVET INC·Filed 2012·Granted Jan 13, 2015·10 cites·23 claims
- 3585US2024084004A1Antibodies against canine pd-1INTERVET INC·Filed 2023·Application pending·0 cites
- 3684US11548859B2Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acidINTERVET INC·Filed 2019·Granted Jan 10, 2023·2 cites·15 claims
- 3784US11530187B2Method for producing (5S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acidINTERVET INC·Filed 2019·Granted Dec 20, 2022·2 cites·16 claims
- 3884US11179372B2Isoxazoline solution containing vitamin E for use with sanitized drinking waterINTERVET INC·Filed 2019·Granted Nov 23, 2021·2 cites·2 claims
- 3984US9827305B2Poultry virus vaccines that are liquid stableINTERVET INC·Filed 2015·Granted Nov 28, 2017·5 cites·23 claims
- 4084US9770440B2Solid oral pharmaceutical compositions for isoxazoline compoundsINTERVET INC·Filed 2013·Granted Sep 26, 2017·5 cites·18 claims
- 4184US9393298B2Liquid stable bovine virus vaccinesINTERVET INC·Filed 2014·Granted Jul 19, 2016·10 cites·22 claims
- 4284US8034845B2Compositions and method for treating infection in cattle and swineINTERVET INC·Filed 2004·Granted Oct 11, 2011·22 cites·5 claims
- 4384US7786329B2Process for preparing ester oxazolidine compounds and their conversion to FlorfenicolINTERVET INC·Filed 2006·Granted Aug 31, 2010·8 cites·85 claims
- 4483US10117839B2Encapsulation of hydrophobic biologically active compoundsINTERVET INC·Filed 2015·Granted Nov 6, 2018·4 cites·18 claims
- 4583US9409954B2Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigensINTERVET INC·Filed 2014·Granted Aug 9, 2016·7 cites·21 claims
- 4683US2024398934A1Feline leukemia virus vaccineINTERVET INC·Filed 2024·Application pending·0 cites
- 4783US2024239759A1Isoxazoline compositions and their use as antiparasiticsINTERVET INC·Filed 2024·Application pending·0 cites
- 4882US10875847B2Aminopyrazoles as selective janus kinase inhibitorsINTERVET INC·Filed 2017·Granted Dec 29, 2020·2 cites·18 claims
- 4982US2025179199A1Antibodies to canine interleukin-4 receptor alphaINTERVET INC·Filed 2024·Application pending·0 cites
- 5081US12252536B2Caninized antibodiesINTERVET INC·Filed 2022·Granted Mar 18, 2025·0 cites·13 claims
Showing the top 50 of 351 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →